Separately, Zacks Investment Research lowered Victrex from a “hold” rating to a “sell” rating in a research report on Tuesday.
Shares of VTXPF remained flat at $$25.62 during mid-day trading on Thursday. The stock had a trading volume of 5 shares, compared to its average volume of 86. The company’s fifty day simple moving average is $26.25. Victrex has a one year low of $24.95 and a one year high of $45.68.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
Read More: Momentum Indicators
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.